FDA Warning Wire: New Woes For Wockhardt
Beleaguered Indian drugmaker Wockhardt leads this week's look at U.S. Food and Drug Administration enforcement actions after inspectors criticized numerous issues at a new manufacturing plant. FDA officials also complained about...To view the full article, register now.
Already a subscriber? Click here to view full article